Literature DB >> 11942320

In vitro comparison of transurethral vaporization of the prostate (TUVP), resection of the prostate (TURP), and vaporization-resection of the prostate (TUVRP).

Oliver Reich1, Stefan Corvin, Ralph Oberneder, Ronald Sroka, Rolf Muschter, Alfons Hofstetter.   

Abstract

PROBLEM: Transurethral vaporization of the prostate (TUVP) and vaporization-resection of the prostate (TUVRP) ("vapor cut, band electrode") seem to be alternatives to conventional resection of the prostate (TURP). For TUVP and TUVRP, little in vitro data has yet been published. The aim of this study was to determine settings for optimal performance with TUVP and TUVRP and to investigate electrosurgical parameters relevant to safety.
METHODS: Standardized experiments were performed on porcine muscle. Mass loss and coagulation zones were measured optically. Additionally, electrical parameters were recorded.
RESULTS: The maximum tissue ablation rates were 3.8 cm3 per min and 6.1 cm3 per min for TUVP and TUVRP, respectively, compared to 6.5 cm3 per min for TURP. The maximum coagulation depths reached 2.1 mm (TUVP), 1.4 mm (TUVRP), and 0.9 mm (TURP). Optimal in vitro settings for TUVP/TUVRP/TURP were as follows: generator power of 250/120/90 W, drag speed of 5/15/20 mm/s, and pressure of 0.40/0.15/0.05 N. Different power generators and electrodes showed considerably varying performance. The energy to remove 1 g of tissue averaged 7.500 J (TUVP), 620 J (TUVRP). and 400 J (TURP).
CONCLUSIONS: These results allow quantification of the influence of different variables on TUVP, TUVRP, and TURP in vitro. The TUVP proves to be an effective ablation alternative. Nevertheless, a 15 to 20 times higher energy demand has to be considered. TUVRP combines excellent ablation features with greater coagulation volumes, indicating better hemostasis.

Mesh:

Year:  2002        PMID: 11942320     DOI: 10.1007/s00240-001-0231-4

Source DB:  PubMed          Journal:  Urol Res        ISSN: 0300-5623


  8 in total

Review 1.  [Laser vaporization of the prostate: all as it should be?].

Authors:  O Reich; M Seitz
Journal:  Urologe A       Date:  2008-04       Impact factor: 0.639

2.  Ex vivo and in vivo investigations of the novel 1,470 nm diode laser for potential treatment of benign prostatic enlargement.

Authors:  Michael Seitz; Robin Ruszat; Thomas Bayer; Derya Tilki; Alexander Bachmann; Christian Stief; Ronald Sroka; Oliver Reich
Journal:  Lasers Med Sci       Date:  2008-08-07       Impact factor: 3.161

3.  [Benign prostatic syndrome (BPS). Ablative treatments].

Authors:  O Reich; M Seitz; C Gratzke; B Schlenker; A Bachmann; C Stief
Journal:  Urologe A       Date:  2006-06       Impact factor: 0.639

4.  Reasons to believe in vaporization: a review of the benefits of photo-selective and transurethral vaporization.

Authors:  Russell N Schwartz; Felix Couture; Iman Sadri; Adel Arezki; David-Dan Nguyen; Ahmed S Zakaria; Kyle Law; Dean Elterman; Malte Rieken; Hannes Cash; Kevin C Zorn
Journal:  World J Urol       Date:  2020-09-15       Impact factor: 4.226

5.  High-power diode laser at 980 nm for the treatment of benign prostatic hyperplasia: ex vivo investigations on porcine kidneys and human cadaver prostates.

Authors:  Michael Seitz; Oliver Reich; Christian Gratzke; Boris Schlenker; Alexander Karl; Markus Bader; Wael Khoder; Florian Fischer; Christian Stief; Ronald Sroka
Journal:  Lasers Med Sci       Date:  2008-02-13       Impact factor: 3.161

6.  Determination of prostate adenoma weight reduction due to vaporisation process occurring during transurethral resection of the prostate.

Authors:  Tomasz Szopinski; Tomasz Golabek; Piotr Chlosta; Andrzej Borówka
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2014-07-19       Impact factor: 1.195

7.  Recurrent symphysitis culminating in pelvic ring fracture after hyperextended transurethral prostate resection and vaporization with symphysis erosion: a case report.

Authors:  Holger Gerullis; Arne Eitzen; Jens Uphoff; Fadi Daaboul; Ajay Chavan; Leander Ermert; Friedhelm Wawroschek; Alexander Winter
Journal:  J Med Case Rep       Date:  2017-05-19

8.  Comparison of PKRP and TUVP in the treatment of high-risk BPH and analysis of postoperative influencing factors.

Authors:  Yao Song; Songqiang Pang; Gongtang Luo; Sen Li; Yaqiang He; Jinqiang Yang
Journal:  Front Surg       Date:  2022-08-03
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.